Vitruvian Shield SA

12/10/2025

🚀 Vitruvian Shield SA Shield achieves Scientific Suitability Recognition from 🇵🇹

We’re proud to announce that Vitruvian Shield–PT LDA with headquarters at PCI · Creative Science Park Aveiro Region has been officially granted Scientific Suitability (Idoneidade Científica) recognition by the Agência Nacional de Inovação (ANI) — a key milestone in our journey to advance digital health, AI-driven research, and decentralized clinical trials.

This recognition, issued under Article 37-A of the Portuguese Investment Tax Code, validates Vitruvian Shield’s R&D capabilities in ICT applied to health, including:
💡 Remote patient monitoring (RPM)
💡 AI-enabled adaptive trial platforms
💡 Continuous digital biomarker discovery
💡 Integration of multi-sensor wearable technologies

It also opens the door to major national and European innovation instruments such as SIFIDE II, Portugal 2030, PRR Health Cluster, and Innosuisse co-funded research programs — reinforcing our mission to bridge clinical research and real-world healthcare through innovation.

We’re deeply grateful to ANI for their trust, and to our multidisciplinary teams in Switzerland, Portugal, and the UAE for their scientific rigor, technological excellence, and commitment to patient-centric innovation.

This milestone marks the next chapter of our expansion — enabling stronger academic and hospital partnerships, accelerating pilot studies in epilepsy, cardiology, diabetes, and oncology, and driving global regulatory readiness for our platform.

🌍 Together, we continue shaping the future of connected clinical research.

02/09/2025

You really want to invest your money with big returns in 3 years? Just check our investment deck and message us if you want to know more about 👌

Decentralized Clinical Trials (DCT) & Remote Patient Monitoring (RPM) Compliance. Data Integrity. Patient-Centric Trials.

23/08/2025

21/08/2025

🌍 At Vitruvian Shield SA, we believe the future of clinical research lies in decentralization, compliance, and patient-centric technology.

Today, our platform is fully ALCOA++ compliant, empowering health institutions to run studies with integrity and regulatory-grade reliability.

We are proud to already support 6 concrete use cases that research teams can adopt immediately:

✅ Short-Term Clinical Studies – fast pilots & feasibility projects
✅ Long-Term Observational Research – chronic disease monitoring over months
✅ Academic Research Programs – 3-month free access for universities & hospitals
✅ Patient Engagement & Self-Reporting – combining subjective and objective data
✅ Digital Biomarker Development – turning wearable signals into predictive insights
✅ Regulatory-Grade Data Repository – audit-ready datasets for CROs & sponsors

💡 Whether you are a hospital, CRO, or academic institution, Vitruvian Shield helps you collect continuous, compliant, and meaningful data that accelerates innovation in digital health.

🚀 And now a big step forward:
👉 Starting 1 September, you will be able to subscribe and begin testing directly on our website.

📣 Academic institutions: get three months of free access to Vitruvian Shield and accelerate your research today.

Let’s shape the future of healthcare research together.

12/08/2025

https://www.eubusinessnews.com/winners/vitruvian-shield-sa-2/
We proud of this new award 💪✨✨✨

Vitruvian Shield Sa is one of the 2025 winners of European CEO of the Year Awards.

02/08/2025

🚀 Meet the Future of Medication Management – In Your Pocket 💊📱

With the Vitruvian Shield SA mobile app, managing medications and prescriptions has never been easier — or friendlier. Designed with both patients and clinicians in mind, our intuitive UI ensures seamless access to:

✅ Digital prescriptions
✅ Smart medication reminders
✅ Real-time treatment updates
✅ Integrated alerts for interactions or missed doses

Whether you’re in the city or a remote village, our app keeps your treatment path clear, organized, and connected to your care team — securely and in real-time.

Because good health starts with good support. 💙